4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-005883
CHIEF MEDICAL OFFICER sold 10,156 shares at $21.03 ($213,581)
- CHIEF MEDICAL OFFICER acquired 10,156 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-02-27 | Option exercise 10b5-1 | +10,156 | $1.86 | $18,890 | 55,048 | D |
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-02-27 | Sale 10b5-1 | −10,156 | $21.03 | $213,581 | 44,892 | D |
| Derivatives | |||||||
| Paolini John F. CHIEF MEDICAL OFFICER | 2024-02-27 | Option exercise · Share Option 10b5-1 | −10,156 | 101,061 | D | ||
| Open-market sales · 10,156 sh · avg $21.03 · $213,581 | |||||||
Loading xslF345X05/form4-02292024_090213.xml…